At our institute, we believe that addressing chronic diseases should not be limited to managing symptoms or living with medications for life. By integrating the latest regenerative medicine technologies and genomic research, we offer comprehensive cellular protocols that target the repair of damaged tissues, the regulation of the immune environment, and the restoration of the body's biological balance from the ground up.

The institute employs a precise and advanced time-bound protocol under the supervision of a select group of physicians and researchers. We perform:

• Advanced Cell Therapy: Utilizing stem cells and stimulating advanced cellular applications capable of directly targeting the pancreas and surrounding tissues.

• Dual Activation Mechanism: Injecting targeted cells that work on two pathways; the first stimulates the regeneration and restoration of insulin-producing beta cells in the pancreas, and the second reduces insulin resistance in peripheral cells.

• Timeline: The protocol includes a customized treatment plan carried out over a full year (an injection session and periodic vital follow-up every 3 months) to ensure the pancreas responds and vital signs remain stable.

• Restoration of Function: Regeneration of damaged pancreatic cells to gradually and naturally resume endogenous insulin production.

• Protection from Complications: Protection of microvascular, peripheral nerve, and retina damage from diabetes, and reduction of HbA1c levels.
  Exceptional Success Rates: Achieving advanced clinical response rates in blood glucose control and reducing reliance on traditional chemotherapy.

The Institute employs a precise and well-developed protocol, supervised by a select group of physicians and researchers. This protocol includes:

• Cellular Regeneration: Utilizing mesenchymal stem cells (MSCs) with immunomodulatory and anti-inflammatory properties for acute and chronic inflammation in the intestines and colon.

• Tissue-Targeting Mechanism: Combining cell therapy with techniques for restoring the gut microbiome balance and injecting growth factors that promote ulcer healing and repair of the gastrointestinal mucosa.

• Schedule: The protocol includes a customized treatment plan implemented over a full year (injection sessions and laboratory monitoring of the digestive system every three months) to ensure the restoration of a healthy and stable intestinal environment.

• Suppression of Inflammatory Attacks: Halting self-destruction in cases of inflammatory bowel diseases (such as Crohn's disease and ulcerative colitis).

• Improvement of Absorption and Digestion: Restoring intestinal function and stimulating normal colonic motility. Exceptional success rates: Achieving scientifically proven clinical success rates of up to 71% in restoring the vital balance of the gut microbiome and radically improving digestion.

The institute employs a precise and well-developed protocol, overseen by a select group of physicians and researchers. This protocol includes:

• Cardiac Cell Applications: Utilizing cardiac progenitor cells and highly purified stem cells capable of differentiating and integrating with vascular muscle tissue.

• Angiogenesis: Injecting cells via specific pathways to stimulate the growth of new blood vessels, improve the elasticity of hardened arteries, and repair damaged cardiac muscle cells resulting from infarction or chronic stress.

• Schedule: The protocol includes a customized treatment plan and close monitoring of cardiac function over a full year (injection sessions and periodic evaluations every three months).

• Enhancing Pumping Efficiency: Improving the ejection fraction of the myocardium and stimulating blood circulation.

• Comprehensive Bioregulation: Sustainable regulation of arterial blood pressure levels, reduction of LDL (bad) cholesterol, and protection of arteries from atherosclerosis.

• Exceptional Success Rates: Achieving a 42% clinical success rate in the immediate response to improved heart muscle function and blood pressure and cholesterol control, significantly reducing the risk of strokes and heart failure.